Clinical Trial: A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07121192) titled 'A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older' on Aug. 06.

Brief Summary: "The purpose of this study is to assess the reactogenicity, safety and immune response of GlaxoSmithKlines (GSK) messenger RNA (mRNA)-based multivalent seasonal influenza vaccine candidates administered in healthy younger and older adults."

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Influenza, Human

Intervention: BIOLOGICAL: Flu mRNA (Formulation A)

One dose of Flu mRNA (Formulation A) received intramuscularly.

BIOLOGICAL: Flu mRNA (Formulation B)

One dose of F...